IRADIMED CORP
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
| | | | | | |
|---|---|---|---|---|---|
| · December 31, · December 31, | |||||
| · 2023 · · 2022 | |||||
| ASSETS · · | |||||
| Current assets: · · | |||||
| Cash and cash equivalents | $49,762,198 | | $57,960,864 | ||
| Accounts receivable, net of allowance for doubtful accounts of $368,835 as of December 31, 2023, and $160,498 as of December 31, 2022 | 12,224,273 | | 13,274,521 | ||
| Inventory, net | 12,821,194 | | 5,369,233 | ||
| Prepaid expenses and other current assets | 1,193,447 | | 630,960 | ||
| Prepaid income taxes | — | | 254,093 | ||
| Total current assets | 76,001,112 | | 77,489,671 | ||
| Property and equipment, net | 9,288,625 | | 2,399,812 | ||
| Intangible assets, net | 2,519,053 | | 2,069,439 | ||
| Operating lease right-of-use asset | 2,043,043 | | 2,205,286 | ||
| Deferred tax asset, net | 2,122,816 | | 700,867 | ||
| Other assets | 181,449 | | 648,672 | ||
| Total assets | $92,156,098 | | $85,513,747 | ||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | ||||
| Current liabilities: | | ||||
| Accounts payable | $1,857,091 | | $1,799,316 | ||
| Accrued payroll and benefits | 2,775,103 | | 2,871,890 | ||
| Other accrued taxes | 103,241 | | 121,919 | ||
| Warranty reserve | 117,463 | | 94,030 | ||
| Deferred revenue | 2,570,407 | | 3,373,122 | ||
| Dividend payable | | 7,975,997 | | | — |
| Current portion of operating lease liabilities | 427,963 | | 293,466 | ||
| Other current liabilities | 250,000 | | — | ||
| Accrued income taxes | 250,041 | | — | ||
| Total current liabilities | 16,327,306 | | 8,553,743 | ||
| Deferred revenue | 2,793,548 | | 1,375,197 | ||
| Operating lease liabilities, less current portion | 1,615,080 | | 1,911,820 | ||
| Total liabilities | 20,735,934 | | 11,840,760 | ||
| Stockholders’ equity: | | ||||
| Common stock; $0.0001 par value; 31,500,000 shares authorized; 12,660,313 shares issued and outstanding as of December 31, 2023, and 12,591,004 shares issued and outstanding as of December 31, 2022 | 1,265 | | 1,259 | ||
| Additional paid-in capital | 28,160,745 | | 26,407,446 | ||
| Retained earnings | 43,258,154 | | 47,264,282 | ||
| Total Stockholders' Equity | 71,420,164 | | 73,672,987 | ||
| Total liabilities and stockholders’ equity | $92,156,098 | | $85,513,747 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.